Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: a three-year randomized clinical trial.

Bang MH, Van Riep T, Thinh NT, Song le H, Dung TT, Van Truong L, Van Don L, Ky TD, Pan D, Shaheen M, Ghoneum M. Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: a three-year randomized clinical trial. Anticancer Res. 2010 Dec; 30(12):5145-51.

View in: PubMed

subject areas

Administration, Cutaneous
Adult
Aged
Aged, 80 and over
alpha-Fetoproteins
Carcinoma, Hepatocellular
Catheter Ablation
Chemoembolization, Therapeutic
Double-Blind Method
Doxorubicin
Ethanol
Ethiodized Oil
Female
Humans
Liver Neoplasms
Male
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Xylans

authors with profiles

Magda A Shaheen, MD, PhD
Mamdooh H Ghoneum, PhD
Deyu Pan

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support